Menu Menu

AZN    Astrazeneca Plc    901832    
Income Statement
Revenue 58,739,000,000
Net Income 10,233,000,000
Profit Margin 17.42%

Balance Sheet
Current Assets 28,723,000,000
Assets 114,074,000,000
Current Liabilities 30,617,000,000
Liabilities 65,355,000,000
Equity 48,719,000,000
Shares Out 1,550,908,000

Cash Flow Statement
Operating Cash Flow 14,575,000,000
Investing Cash Flow -6,808,000,000

Market Analysis
Market Cap 303,487,287,226
Price 194.81
BVPS 31.41
PB 6.20
EPS 6.55
PE 29.76
PS 1.29
FCF 7,767,000,000
Dividends
Dividend Amount 0.50   
Dividend Yield 1.48%
Jan Feb Mar
Ex: 2/22 Pay: 3/25
Apr May Jun
Jul Aug Sep
Ex: 8/9 Pay: 9/9
Oct Nov Dec

Earnings
Jan Feb Mar
2/08
Apr May Jun
4/25
Jul Aug Sep
7/25
Oct Nov Dec
11/12

Find a discrepancy? The most accurate way to find company fundamental data is to view AZN documents filed with the SEC.


AZN Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: